Aethlon Medical files Amendment No. 1 to Prospectus Supplement; up to $542,716 remaining in ATM offering

AETHLON MEDICAL INC

Filed Amendment No. 1 to Prospectus Supplement under S-3 Registration Statement (File No. 333-292405) on June 4, 2026.
Remaining aggregate offering price of $542,716 in common stock may be sold under ATM Agreement with H.C. Wainwright & Co.
Previously sold $1,849,457 in shares under the same Prospectus Supplement before the amendment.
As of June 1, 2026, shares outstanding: 2,344,886; public float: 2,337,629 shares held by non-affiliates.
All other terms of the offering and ATM Agreement remain unchanged.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.